Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression

AIDS Research and Human Retroviruses

Volumn 28, Issue 3, 2012, Pages 289-294

  Redd, Andrew D ^a   Laeyendecker, Oliver ^a,b   Kong, Xiangrong ^c   Kiwanuka, Noah ^d,e,f   Lutalo, Tom ^d   Huang, Wei ^g   Gray, Ronald H ^c   Wawer, Maria J ^c   Serwadda, David ^f   Eshleman, Susan H ^b   Quinn, Thomas C ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^e UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^f MAKERERE UNIVERSITY   (Uganda)

^g MONOGRAM BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ADULT; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; STATISTICAL MODEL; UGANDA;

ADULT; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV SEROPOSITIVITY; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CCR5; RECEPTORS, CXCR4; UGANDA;

EID: 84863295391     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0006     Document Type: Article

References (25)

1. Wyatt R and Sodroski J: The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens. Science 1998;280: 1884-1888. (Pubitemid 28299385)
2. Nedellec R, Coetzer M, Shimizu N, et al.: Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype. J Virol 2009;83: 8353-8363.
3. Dean M, Carrington M, Winkler C, et al.: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856-1862.
4. Wade J, Sterjovski J, Gray L, et al.: Enhanced CD4 + cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection. Virology 2009;396:246-255.
5. Yu X, McLane MF, Ratner L, et al.: Killing of primary CD4 + T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1994;91:10237-10241.
6. Etemad B, Fellows A, Kwambana B, et al.: Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection. J Virol 2009;83:9694-9708.
7. Huang W, Eshleman SH, Toma J, et al.: Coreceptor tropism in human immunodeficiency virus type 1 subtype D: High prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol 2007;81:7885-7893. (Pubitemid 47101474)
8. Bjorndal A, Deng H, Jansson M, et al.: Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997;71: 7478-7487. (Pubitemid 27391688)
9. Bjorndal A, Sonnerborg A, Tscherning C, Albert J, and Fe-nyo EM: Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res Hum Retroviruses 1999;15:647-653. (Pubitemid 29205668)
10. Peeters M, Vincent R, Perret JL, et al.: Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:115-121. (Pubitemid 29063708)
11. Blaak H, van't Wout AB, Brouwer M, Hooibrink B, Ho-venkamp E, and Schuitemaker H: In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syn-cytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc Natl Acad Sci USA 2000;97: 1269-1274. (Pubitemid 30080848)
12. Connor RI, Sheridan KE, Ceradini D, Choe S, and Landau NR: Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997;185:621-628. (Pubitemid 27098147)
13. Platt EJ, Kozak SL, and Kabat D: Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 2000;16:871-882. (Pubitemid 30399607)
14. Goetz MB, Leduc R, Kostman JR, et al.: Relationship between HIV coreceptor tropism and disease progression in persons with untreated chronic HIV infection. J Acquir Immune Defic Syndr 2009;50:259-266.
15. Salazar-Gonzalez JF, Salazar MG, Keele BF, et al.: Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 2009;206:1273-1289.
16. Zhu T, Mo H, Wang N, et al.: Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993;261:1179-1181. (Pubitemid 23300886)
17. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al.: Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 2008;105:7552-7557. (Pubitemid 351830056)
18. Pollakis G, Abebe A, Kliphuis A, et al.: Phenotypic and ge-notypic comparisons of CCR5-and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals. J Virol 2004;78:2841-2852. (Pubitemid 38314342)
19. Coetzer M, Nedellec R, Salkowitz J, et al.: Evolution of CCR5 use before and during coreceptor switching. J Virol 2008;82: 11758-11766.
20. Laeyendecker O, Redd AD, Lutalo T, et al.: Frequency of long-term nonprogressors in hiv-1 seroconverters from rakai uganda. J Acquir Immune Defic Syndr 2009;52:316-319.
21. Lutalo T, Gray RH, Wawer M, et al.: Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda. AIDS 2007;21(Suppl 6):S15-19. (Pubitemid 350158884)
22. Wawer MJ, Gray RH, Sewankambo NK, et al.: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191:1403-1409. (Pubitemid 40563350)
23. Collinson-Streng AN, Redd AD, Sewankambo NK, et al.: Geographic HIV type 1 subtype distribution in Rakai district, Uganda. AIDS Res Hum Retroviruses 2009;25:1045-1048.
24. Whitcomb JM, Huang W, Fransen S, et al.: Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrob Agents Chemother 2007;51: 566-575. (Pubitemid 46185274)
25. van Rij RP, Blaak H, Visser JA, et al.: Differential coreceptor expression allows for independent evolution of non-syncy-tium-inducing and syncytium-inducing HIV-1. J Clin Invest 2000;106:1039-1052.